SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 8th, 2024 Company Industry JurisdictionTHIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Monica R. Thomas, an individual (“Employee”) is made and entered into effective as of August 6, 2024. Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”
THIRD AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 8th, 2024 Company Industry JurisdictionTHIS THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Terry Murdock, an individual (“Employee”) is made and entered into effective as of August 6, 2024. Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 8th, 2024 Company Industry JurisdictionTHIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Andrew Perry, an individual (“Employee”) is made and entered into effective as of August 6, 2024. Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”
FOURTH AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 7th, 2024 Company Industry JurisdictionTHIS FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Rajesh Malik, an individual (“Employee”) is made and entered into effective as of August 6, 2024. Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 7th, 2024 Company Industry JurisdictionTHIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Mark Avagliano, an individual (“Employee”) is made and entered into effective as of August 6, 2024. Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 7th, 2024 Company Industry JurisdictionTHIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and John W. Umstead V, an individual (“Employee”) is made and entered into effective as of August 6, 2024. Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 7th, 2024 Company Industry JurisdictionTHIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and John E. Bailey, Jr., an individual (“Employee”) is made and entered into effective as of August 6, 2024. Employee and the Company may be individually referred to as a “Party” and collectively as the “Parties.”